Cargando…
The interaction of ifosfamide and aprepitant in gynecologic malignancies()
• Aprepitant combined with ifosfamide may lead to encephalopathy. • Aprepitant–ifosfamide induced encephalopathy was of short duration in these cases.
Autores principales: | Shindorf, Mackenzie L., Manahan, Kelly J., Geisler, John P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862235/ https://www.ncbi.nlm.nih.gov/pubmed/24371715 http://dx.doi.org/10.1016/j.gynor.2013.06.002 |
Ejemplares similares
-
Ifosfamide-induced Encephalopathy Precipitated by Aprepitant: A Rarely Manifested Side Effect of Drug Interaction
por: Kataria, Pritam Sureshchandra, et al.
Publicado: (2017) -
Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant?
por: Séjourné, Alice, et al.
Publicado: (2014) -
OTHR-16. CONCURRENT USE OF APREPITANT AND IFOSFAMIDE IN PEDIATRIC CANCER PATIENTS
por: Winzent, Shelby, et al.
Publicado: (2020) -
Single-Agent Thalidomide for Treatment of Malignant Paraganglioma of the Organ of Zuckerkandl
por: Shindorf, Mackenzie L., et al.
Publicado: (2019) -
Effective Treatment of a Malignant Breast Phyllodes Tumor with Doxorubicin-Ifosfamide Therapy
por: Yamamoto, Shinya, et al.
Publicado: (2019)